Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CRD-B Stock Summary
Top 10 Correlated ETFs
CRD-B
In the News
Crawford & Company (CRD.B) Q4 2023 Earnings Call Transcript
Crawford & Company (NYSE:CRD.B ) Q4 2023 Earnings Conference Call March 5, 2024 8:30 AM ET Company Participants Rohit Verma - President, Chief Executive Officer Bruce Swain - Chief Financial Officer Tami Stevenson - General Counsel Conference Call Participants Maxwell Fritscher - Truist Securities Kevin Steinke - Barrington Research Operator Good morning. My name is Lara and I will be your conference facilitator today.
Crawford & Company: Profit From The Eye Of The Storm
Global insured catastrophe losses have exceeded $100bn for the fourth consecutive year, indicating a long-term trend. Insurance and reinsurance companies are one way to invest in this trend, but service providers to the insurance industry can also profit. Crawford & Company, a leading global loss-adjusting company, is well-positioned to capture growth and improve margins with its data and tech capabilities.
Crawford & Company B (CRD.B) is on the Move, Here's Why the Trend Could be Sustainable
Crawford & Company B (CRD.B) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Future Fortunes: 3 Stocks Under $15 With Potential for Huge Returns
Three underappreciated stocks shine brightly in a bustling market where big-ticket stocks often hog the limelight. Each is valued under $15 but holds immense potential for exponential growth.
Tomorrow's Titans: 3 Stocks Under $10 Poised for Explosive Growth
In the ever-evolving landscape of the stock market, identifying undervalued stocks with exponential growth potential is akin to discovering hidden gems. Amidst this pursuit, three stocks under $10 emerge as promising contenders in their respective industries.
Recent Price Trend in Crawford & Company B (CRD.B) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Crawford & Company B (CRD.B) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Crawford & Company B (CRD.B) Is a Great Choice for 'Trend' Investors, Here's Why
Crawford & Company B (CRD.B) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Is Crawford & Company B (CRD.B) a Solid Growth Stock? 3 Reasons to Think "Yes"
Crawford & Company B (CRD.B) could produce exceptional returns because of its solid growth attributes.
Crawford & Company B (CRD.B) is on the Move, Here's Why the Trend Could be Sustainable
Crawford & Company B (CRD.B) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Crawford (CRD.A) Is a Great Choice for 'Trend' Investors, Here's Why
Crawford (CRD.A) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
CRD-B Financial details
CRD-B Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 19.54 | 19.13 | 21.5 | 24.89 | 26.97 | |
Net income per share | 0.18 | 0.53 | 0.58 | -0.37 | 0.63 | |
Operating cash flow per share | 1.4 | 1.75 | 1.02 | 0.56 | 2.13 | |
Free cash flow per share | 1.01 | 1.05 | 0.44 | -0.14 | 1.38 | |
Cash per share | 0.97 | 0.84 | 1 | 0.93 | 1.2 | |
Book value per share | 2.97 | 3.52 | 4 | 2.52 | 2.9 | |
Tangible book value per share | -1.07 | -0.41 | -1.48 | -2.51 | -2.36 | |
Share holders equity per share | 2.97 | 3.52 | 4 | 2.52 | 2.9 | |
Interest debt per share | 5.7 | 4.66 | 5.57 | 7.21 | 6.78 | |
Market cap | 614.93M | 392.65M | 396.95M | 275.07M | 643.65M | |
Enterprise value | 857.91M | 587.56M | 632.38M | 575.46M | 896.81M | |
P/E ratio | 64.55 | 13.88 | 12.93 | -14.84 | 21.03 | |
Price to sales ratio | 0.59 | 0.39 | 0.35 | 0.22 | 0.49 | |
POCF ratio | 8.18 | 4.21 | 7.31 | 9.95 | 6.2 | |
PFCF ratio | 11.37 | 7.04 | 16.99 | -39.49 | 9.58 | |
P/B Ratio | 3.86 | 2.1 | 1.87 | 2.21 | 4.54 | |
PTB ratio | 3.86 | 2.1 | 1.87 | 2.21 | 4.54 | |
EV to sales | 0.82 | 0.58 | 0.56 | 0.47 | 0.68 | |
Enterprise value over EBITDA | 8.17 | 5.92 | 6.98 | 6.52 | 8.71 | |
EV to operating cash flow | 11.41 | 6.31 | 11.64 | 20.82 | 8.64 | |
EV to free cash flow | 15.86 | 10.53 | 27.06 | -82.62 | 13.35 | |
Earnings yield | 0.02 | 0.07 | 0.08 | -0.07 | 0.05 | |
Free cash flow yield | 0.09 | 0.14 | 0.06 | -0.03 | 0.1 | |
Debt to equity | 1.85 | 1.28 | 1.36 | 2.78 | 2.2 | |
Debt to assets | 0.39 | 0.32 | 0.34 | 0.44 | 0.39 | |
Net debt to EBITDA | 2.31 | 1.97 | 2.6 | 3.4 | 2.46 | |
Current ratio | 1.33 | 1.24 | 1.14 | 1.26 | 1.23 | |
Interest coverage | 5.98 | 7.45 | 7.69 | 5.06 | 3.39 | |
Income quality | 7.9 | 3.44 | 1.78 | -1.49 | 3.43 | |
Dividend Yield | 0.02 | 0.02 | 0.03 | 0.04 | 0.02 | |
Payout ratio | 1.38 | 0.34 | 0.41 | -0.64 | 0.41 | |
Sales general and administrative to revenue | 0.22 | 0.22 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.29 | 0.28 | 0.34 | 0.31 | 0.32 | |
Capex to operating cash flow | -0.28 | -0.4 | -0.57 | -1.25 | -0.35 | |
Capex to revenue | -0.02 | -0.04 | -0.03 | -0.03 | -0.03 | |
Capex to depreciation | -0.52 | -0.93 | -0.77 | -0.96 | -1.02 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0 | 0 | |
Graham number | 3.45 | 6.49 | 7.22 | 4.61 | 6.4 | |
ROIC | 0.05 | 0.07 | 0.06 | -0.33 | 0.08 | |
Return on tangible assets | 0.02 | 0.05 | 0.05 | -0.03 | 0.06 | |
Graham Net | -6.78 | -6.6 | -7.44 | -9.66 | -8.42 | |
Working capital | 78.94M | 59.21M | 42.07M | 71.78M | 70.05M | |
Tangible asset value | -57.29M | -21.81M | -78.5M | -124.26M | -115.45M | |
Net current asset value | -279.93M | -264.05M | -295.32M | -316.86M | -290.02M | |
Invested capital | 1.85 | 1.28 | 1.36 | 2.78 | 2.2 | |
Average receivables | 241.71M | 233.89M | 242.99M | 267.3M | 264.65M | |
Average payables | 36.11M | 37.96M | 45.01M | 49.66M | 47.98M | |
Average inventory | 0 | 0 | 0 | -63.14M | -63.14M | |
Days sales outstanding | 83.59 | 81.84 | 82.7 | 81.96 | 70.07 | |
Days payables outstanding | 16.67 | 20.57 | 20.88 | 20.07 | 17.19 | |
Days of inventory on hand | 0 | 0 | 0 | -49.83 | 0 | |
Receivables turnover | 4.37 | 4.46 | 4.41 | 4.45 | 5.21 | |
Payables turnover | 21.9 | 17.75 | 17.48 | 18.19 | 21.23 | |
Inventory turnover | 0 | 0 | 0 | -7.32 | 0 | |
ROE | 0.06 | 0.15 | 0.14 | -0.15 | 0.22 | |
Capex per share | -0.39 | -0.7 | -0.58 | -0.7 | -0.75 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.86 | 6.69 | 6.84 | 6.89 | 6.57 | |
Net income per share | -0.29 | 0.22 | 0.17 | 0.25 | -0.02 | |
Operating cash flow per share | 0.9 | -0.01 | 0.57 | 0.84 | 0.73 | |
Free cash flow per share | 0.7 | -0.19 | 0.38 | 0.64 | 0.55 | |
Cash per share | 0.95 | 0.89 | 0.97 | 1 | 1.19 | |
Book value per share | 2.56 | 2.95 | 3.1 | 3.36 | 2.9 | |
Tangible book value per share | -2.56 | -2.26 | -2.13 | -1.88 | -2.36 | |
Share holders equity per share | 2.56 | 2.95 | 3.1 | 3.36 | 2.9 | |
Interest debt per share | 7.22 | 7.48 | 7.26 | 6.72 | 6.47 | |
Market cap | 270.08M | 405.88M | 541.24M | 457.45M | 644.05M | |
Enterprise value | 570.47M | 721.33M | 842.91M | 731.86M | 897.22M | |
P/E ratio | -4.73 | 9.5 | 16.06 | 9.28 | -196.84 | |
Price to sales ratio | 0.81 | 1.25 | 1.62 | 1.35 | 2.01 | |
POCF ratio | 6.16 | -912.09 | 19.6 | 11.18 | 18.03 | |
PFCF ratio | 7.91 | -44.67 | 29.56 | 14.68 | 24.03 | |
P/B Ratio | 2.17 | 2.83 | 3.58 | 2.78 | 4.55 | |
PTB ratio | 2.17 | 2.83 | 3.58 | 2.78 | 4.55 | |
EV to sales | 1.71 | 2.22 | 2.53 | 2.17 | 2.8 | |
Enterprise value over EBITDA | 26.52 | 24.49 | 30.42 | 21.94 | 74.08 | |
EV to operating cash flow | 13.02 | -1.62K | 30.52 | 17.89 | 25.12 | |
EV to free cash flow | 16.71 | -79.39 | 46.04 | 23.48 | 33.48 | |
Earnings yield | -0.05 | 0.03 | 0.02 | 0.03 | 0 | |
Free cash flow yield | 0.13 | -0.02 | 0.03 | 0.07 | 0.04 | |
Debt to equity | 2.78 | 2.51 | 2.31 | 1.97 | 2.2 | |
Debt to assets | 0.44 | 0.44 | 0.42 | 0.39 | 0.39 | |
Net debt to EBITDA | 13.97 | 10.71 | 10.89 | 8.23 | 20.9 | |
Current ratio | 1.26 | 1.29 | 1.3 | 1.31 | 1.23 | |
Interest coverage | 3.11 | 4.64 | 3.73 | 3.61 | 0.76 | |
Income quality | -3.07 | -0.04 | 3.31 | 3.36 | -36.11 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | -0.2 | 0.27 | 0.35 | 0.28 | -4.18 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.31 | 0.31 | 0.31 | 0.31 | 0.32 | |
Capex to operating cash flow | -0.22 | 19.42 | -0.34 | -0.24 | -0.25 | |
Capex to revenue | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | |
Capex to depreciation | -1.11 | -0.95 | -1.01 | -1.07 | -1.06 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.12 | 3.82 | 3.47 | 4.36 | 1.04 | |
ROIC | -0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Return on tangible assets | -0.03 | 0.02 | 0.01 | 0.02 | 0 | |
Graham Net | -9.84 | -8.49 | -8.2 | -8.17 | -8.42 | |
Working capital | 71.78M | 82.21M | 85.79M | 89.31M | 70.05M | |
Tangible asset value | -124.26M | -109.57M | -103.8M | -92M | -115.45M | |
Net current asset value | -316.86M | -305.7M | -296.75M | -284.23M | -290.02M | |
Invested capital | 2.78 | 2.51 | 2.31 | 1.97 | 2.2 | |
Average receivables | 285.79M | 284.17M | 295.24M | 292.63M | 269.73M | |
Average payables | 46.51M | 48.81M | 45.44M | 44.28M | 44.79M | |
Average inventory | -130.46M | -63.14M | 0 | 0 | 0 | |
Days sales outstanding | 74.64 | 80.92 | 80.53 | 76.4 | 70.9 | |
Days payables outstanding | 18.35 | 17.64 | 16.06 | 16.54 | 17.65 | |
Days of inventory on hand | -45.58 | 0 | 0 | 0 | 0 | |
Receivables turnover | 1.21 | 1.11 | 1.12 | 1.18 | 1.27 | |
Payables turnover | 4.9 | 5.1 | 5.6 | 5.44 | 5.1 | |
Inventory turnover | -1.97 | 0 | 0 | 0 | 0 | |
ROE | -0.11 | 0.07 | 0.06 | 0.07 | -0.01 | |
Capex per share | -0.2 | -0.18 | -0.19 | -0.2 | -0.18 |
CRD-B Frequently Asked Questions
What is Crawford & Company stock symbol ?
Crawford & Company is a US stock , located in Atlanta of Ga and trading under the symbol CRD-B
Is Crawford & Company buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $11. The lowest prediction is $11 and the highest is $11
What is CRD-B stock prediction ?
What is Crawford & Company stock quote today ?
Crawford & Company stock price is $9.0815 today.
Is Crawford & Company stock public?
Yes, Crawford & Company is a publicly traded company.